Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.380
+0.030 (0.90%)
Apr 30, 2025, 3:04 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Traditional Chinese Medicine Formula Granules and Decoction Pieces
2.92B
Log In
Log In
Log In
Log In
Traditional Chinese Medicine Formula Granules and Decoction Pieces Growth
-12.99%
Log In
Log In
Log In
Log In
Blood-essential Injection
851.29M
Log In
Log In
Log In
Log In
Blood-essential Injection Growth
4.23%
Log In
Log In
Log In
Log In
Smart Pharmaceutical Supply Chain
714.90M
Log In
Log In
Log In
Log In
Smart Pharmaceutical Supply Chain Growth
21.66%
Log In
Log In
Log In
Log In
Medical Device
383.12M
Log In
Log In
Log In
Log In
Medical Device Growth
-43.12%
Log In
Log In
Log In
Log In
Excipients
343.71M
Log In
Log In
Log In
Log In
Excipients Growth
-4.80%
Log In
Log In
Log In
Log In
Low Molecular Weight Heparin Calcium Injection
287.21M
Log In
Log In
Log In
Log In
Low Molecular Weight Heparin Calcium Injection Growth
-5.82%
Log In
Log In
Log In
Log In
Moxifloxacin Hydrochloride Sodium Chloride Injection
189.43M
Log In
Log In
Log In
Log In
Moxifloxacin Hydrochloride Sodium Chloride Injection Growth
14.49%
Log In
Log In
Log In
Log In
Other Products
188.86M
Log In
Log In
Log In
Log In
Other Products Growth
-18.85%
Log In
Log In
Log In
Log In
API
156.24M
Log In
Log In
Log In
Log In
API Growth
6.07%
Log In
Log In
Log In
Log In
Other
70.76M
Log In
Log In
Log In
Log In
Other Growth
7654.97%
Log In
Log In
Log In
Log In
Fasudil Hydrochloride Injection
-
Log In
Log In
Log In
Log In
Fasudil Hydrochloride Injection Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
China
5.17B
Log In
Log In
Log In
Log In
China Growth
-12.77%
Log In
Log In
Log In
Log In
Overseas
361.28M
Log In
Log In
Log In
Log In
Overseas Growth
-50.29%
Log In
Log In
Log In
Log In